Colgate-palmolive Company (CL)
NYSE:CL
Want to see CL full AI Analyst Report?
CL Stock Chart & Stats
$85.81
-$0.03(-0.03%)
At close: 4:00 PM EST
$85.81
-$0.03(-0.03%)
Day’s Range― - ―
52-Week Range$74.55 - $99.33
Previous CloseN/A
Volume1.11M
Average Volume (3M)5.27M
Market Cap
$70.63B
Enterprise Value$78.76B
Total Cash (Recent Filing)$1.42B
Total Debt (Recent Filing)$7.97B
Price to Earnings (P/E)32.6
Beta0.11
Next Earnings
Jul 31, 2026EPS Estimate
0.95Next Dividend Ex-DateN/A
Dividend Yield2.67%
Share Statistics
EPS (TTM)2.59
Shares Outstanding800,189,330
10 Day Avg. Volume5,167,993
30 Day Avg. Volume5,269,309
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)1.18K
Price to Sales (P/S)3.14
P/FCF Ratio17.58
Enterprise Value/Market Cap1.12
Enterprise Value/Revenue3.79
Enterprise Value/Gross Profit6.31
Enterprise Value/Ebitda20.11
Forecast
1Y Price Target
$96.00Price Target Upside11.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
EPS Forecast (FY)3.8
Revenue Forecast (FY)$21.48B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent, sizable operating and free cash flow delivers durable financial flexibility: it funds dividends, investments in advertising/innovation, and productivity programs without immediate reliance on external financing, supporting long-term competitiveness even amid cyclical headwinds.
High Margins And Steady Revenue GrowthColgate's staple CPG model and scale sustain high gross margins and steady top-line expansion. Strong brand pricing, repeat purchase behavior and distribution breadth underpin durable margin economics and predictable cash flows across consumer staples cycles.
Hill's Pet Nutrition StrengthHill's Prescription and Science Diets drive durable, higher‑value revenue via veterinary/professional channels and prescription stickiness. Consistent share gains and multi‑channel penetration diversify Colgate's portfolio and boost resilience versus commodity-driven categories.
Bears Say
Very High LeverageAn extremely thin equity base and outsized reported leverage materially limit financial flexibility. Even with strong cash flow, high leverage increases refinancing and rating risk, constrains M&A or share actions, and amplifies downside during macro shocks.
Sustained Margin Pressure From Commodities/logisticsLarge, multi‑month commodity and logistics cost inflation plus tariff effects in North America compress gross margins. Management expects these pressures to persist through 2026 while productivity benefits are weighted to later years, leaving a durable near‑term margin gap.
Expanded Restructuring Cash Charges & Execution RiskBroader restructuring increases near-term cash outflows and execution complexity across regions and Hill's operations. While intended to lift long-term efficiency, these sizable, mostly cash charges raise implementation risk and temporarily strain operating liquidity and management focus.
Colgate-Palmolive News
CL FAQ
What was Colgate-palmolive Company’s price range in the past 12 months?
Colgate-palmolive Company lowest stock price was $74.55 and its highest was $99.33 in the past 12 months.
What is Colgate-palmolive Company’s market cap?
Colgate-palmolive Company’s market cap is $70.63B.
When is Colgate-palmolive Company’s upcoming earnings report date?
Colgate-palmolive Company’s upcoming earnings report date is Jul 31, 2026 which is in 57 days.
How were Colgate-palmolive Company’s earnings last quarter?
Colgate-palmolive Company released its earnings results on May 01, 2026. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.943 by $0.027.
Is Colgate-palmolive Company overvalued?
According to Wall Street analysts Colgate-palmolive Company’s price is currently Undervalued.
Does Colgate-palmolive Company pay dividends?
Colgate-palmolive Company pays a Quarterly dividend of $0.52 which represents an annual dividend yield of 2.67%. See more information on Colgate-palmolive Company dividends here
What is Colgate-palmolive Company’s EPS estimate?
Colgate-palmolive Company’s EPS estimate is 0.95.
How many shares outstanding does Colgate-palmolive Company have?
Colgate-palmolive Company has 800,189,330 shares outstanding.
What happened to Colgate-palmolive Company’s price movement after its last earnings report?
Colgate-palmolive Company reported an EPS of $0.97 in its last earnings report, beating expectations of $0.943. Following the earnings report the stock price went up 2.226%.
Which hedge fund is a major shareholder of Colgate-palmolive Company?
Currently, no hedge funds are holding shares in CL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Colgate-Palmolive Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$96.00 (11.88% Upside)
$96.00 (11.88% Upside)
Blogger Sentiment
Bullish
CL Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 3.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $955.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.97%
12-Months-Change
Fundamentals
Return on Equity
475.13%
Trailing 12-Months
Asset Growth
-0.22%
Trailing 12-Months
Company Description
Colgate-palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
CL Company Deck
CL Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced encouraging operational and strategic progress — accelerated organic sales, volume + pricing gains excluding private-label pet impact, strong Hill's performance, emerging-market momentum, and an expanded productivity program — against meaningful near-term margin headwinds: roughly $300 million of incremental cost pressure, elevated commodity and logistics inflation (>20% and ~10% respectively), gross margin degradation, North America underperformance, and temporary private-label pet disruption. Management maintained overall sales and EPS guidance and emphasized offset plans (RGM, pricing via innovation, productivity/SGPP, disciplined advertising), but acknowledged persistent macro uncertainty.View all CL earnings summariesCL Net sales Breakdown
77.37% Oral, Personal and Home Care
22.63% Pet Nutrition
CL Stock 12 Month Forecast
Average Price Target
$96.00
▲(11.88% Upside)
Technical Analysis
Ownership Overview
0.15% Insiders
20.97% Mutual Funds
16.27% Other Institutional Investors
38.60% Public Companies and Individual Investors